Shenzhen Dobot Corp Ltd (Ticker: 2432 HK) is a robotics company specializing in industrial automation and the development of collaborative robots (cobots) for human-machine collaboration. The company offers eight main product lines, covering payloads from 0.25 kg to 20 kg, and serves over 15 industries, including consumer electronics, automotive, metal processing, semiconductor, and healthcare. Since its founding in 2015, Dobot has sold over 72,000 robots to customers in 80 countries and regions, ranking first in Chinese robot exports by volume for five consecutive years.

Shenzhen Dobot Corp Ltd will list on the Hong Kong Stock Exchange on December 23, 2024. The IPO includes 40 million shares with an expected price range of HKD 18.80 to HKD 20.80, aiming to raise approximately HKD 832 million (USD 107 million). The offering is managed by ABCI Capital Ltd, China PA Securities Hong Kong Co. Ltd, Guotai Junan Securities (Hong Kong) Ltd, Shenwan Hongyuan Securities HK Ltd, and TradeGo Markets.

Minieye Technology Co Ltd (Ticker: 2431 HK) is a China-based company specializing in automotive and truck parts and equipment, with a focus on intelligent driving solutions, smart cockpits, and vehicle-to-road collaboration systems. Minieye develops full-stack, self-developed autonomous driving solutions supporting levels L0 to L4, enhancing safety and comfort in driving experiences. The company also provides advanced solutions for connected vehicles and smart cities.

Minieye Technology will list on the Hong Kong Stock Exchange on December 27, 2024. The IPO includes 39.19 million shares with an expected price range of HKD 17.00 to HKD 20.20, aiming to raise approximately HKD 791.64 million (USD 101.89 million). The offering is managed by ABCI Capital Ltd, BOCI Asia Ltd, CLSA Ltd, CMBC Securities Co. Ltd, China International Capital Corp HK Securities, and Fosun International Securities Ltd.

A greenshoe option of 15% (5.88 million shares) is available, though no details on its exercise have been disclosed. The expected market capitalization at the offer has not been announced.

Xunfei Healthcare Technology Co Ltd (Ticker: 2506 HK) is a healthcare technology company and a subsidiary of iFLYTEK, specializing in artificial intelligence (AI) applications for the medical sector. Founded in 2016, the company integrates AI technologies such as speech and image recognition, natural language understanding, and large language models to enhance medical diagnosis, chronic disease management, and hospital information systems. Xunfei Healthcare aims to improve access to quality care, empower community-level medical services, and support national healthcare reform policies.

Xunfei Healthcare will list on the Hong Kong Stock Exchange on December 30, 2024. The IPO includes 7.04 million shares priced at HKD 82.80 each, targeting proceeds of HKD 582.54 million (USD 74.97 million). The offering is managed by ABCI Capital Ltd, Advent Securities Hong Kong Ltd, CCB International Capital Ltd, CMBC Securities Co Ltd, and China Galaxy International Securities.

HealthyWay Inc (Ticker: 2587 HK) is an internet-based health and wellness service provider operating one of the largest digital health platforms in China. Established in 2001 and headquartered in the Cayman Islands, the company offers a wide range of services, including health membership schemes, remote medical consultations, pharmaceutical sales, and digital marketing solutions for corporations and institutions in the healthcare sector. HealthyWay leverages its platform to connect individual users, healthcare providers, and corporate clients, enabling accessible health management and efficient healthcare operations.

HealthyWay will list on the Hong Kong Stock Exchange on December 30, 2024. The IPO includes 25 million shares with an expected price range of HKD 7.80 to HKD 8.80, aiming to raise approximately HKD 220 million (USD 28.31 million). The offering is managed by BOCI Asia Ltd, China Everbright Securities (HK), Fosun International Securities Ltd, Futu Securities International Hong Kong Ltd, Livermore Holdings Ltd, and Ruibang Securities Ltd.

InnoScience Suzhou Technology Holding Co Ltd (Ticker: 2577 HK) is a semiconductor company specializing in Gallium Nitride (GaN) technology. GaN is a wide-bandgap semiconductor material known for its high efficiency, fast switching speeds, and ability to operate at higher voltages and temperatures compared to traditional silicon. It is widely used in power electronics, enabling compact, energy-efficient solutions for consumer electronics, renewable energy systems, automotive electronics, and data centers. As the world's largest Integrated Device Manufacturer (IDM) fully focused on 8-inch GaN-on-Si processes, InnoScience designs and manufactures advanced GaN devices to meet diverse application needs.

InnoScience Suzhou Technology will list on the Hong Kong Stock Exchange on December 30, 2024. The IPO includes 45.36 million shares with an expected price range of HKD 30.86 to HKD 33.66, aiming to raise approximately HKD 1.53 billion (USD 196.50 million). The offering is managed by ABCI Capital Ltd, BOCI Asia Ltd, CLSA Ltd, CMB International Capital Corp Ltd, and China International Capital Corp HK Securities.